Avista Capital Partners
Avista Capital Partners Completes Acquisition of BioReliance Corporation from Invitrogen Corporation
Published in Gastroenterology Week, April 23rd, 2007
Avista Capital Partners, a leading private equity firm, announced it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ:IVGN) for approximately $210 million. BioReliance is a leading contract service organization providing biological safety testing, toxicology, viral manufacturing, and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries globally.
Tim Derrington, who served as General Manager of BioReliance under Invitrogen, has been appointed CEO. Charles Harwood has been appointed Executive Chairman of the BioReliance Board of Directors. Mr. Harwood was previously...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Kidney Cancer
Mouse FH knockout resembles human renal cell cancer - Lyme Disease
'Combination' Lyme disease vaccine proteins patented - Banyan Corporation
Banyan's Diagnostic Subsidiaries Continue to Grow - Biomedical Engineering
Natus Medical Receives Medical Design Excellence Award for the Olympic Cool-Cap - Breast Cancer Screening
Sectra to Distribute iCAD SecondLook Digital Product to Growing Digital Mammography Market - Cancer
FASgen Awarded NCI Grant and Also Announces Significant Developments in its Cancer Research Program - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
